The Andean Trade Preference Act (ATPA) (19 U.S.C. 3201 et seq.) authorizes the President to proclaim duty-free treatment for eligible articles from Bolivia, Colombia, Ecuador, and Peru in order to help these countries fight drug production and trafficking by expanding their economic alternatives. Section 206 of ATPA (19 U.S.C. 3204) requires the Commission to submit to Congress and the President biennial reports regarding the economic impact of the act on U.S. industries and consumers, and, in conjunction with other agencies, the effectiveness of the act in promoting drug-related crop eradication and crop substitution efforts of the beneficiary countries.

For Industry and Economic Analysis publications on the Western Hemisphere, please visit: www.usitc.gov/commission_publications_library and search for "Western Hemisphere."